All stock lists
TuHURA Biosciences, Inc./NV (HURA)
NASDAQ: HURA · Real-Time Price · USD
Healthcare · Biotechnology
$1.37-$0.03 (-2.14%)
Insider Score
––Not scored
HURA Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
HURA Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | $1.96 M | $2.14 M | $2.30 M | -$1.56 M | $1.59 M | — |
| R&D Expense | $3.70 M | $6.62 M | $5.23 M | $6.06 M | $4.97 M | — |
| Operating Expenses | $5.66 M | $8.76 M | $7.53 M | $4.38 M | $6.42 M | — |
| Operating Income | -$5.66 M | -$8.76 M | -$7.53 M | -$4.38 M | -$6.42 M | — |
| Pretax Income | -$6.41 M | -$9.22 M | -$7.54 M | -$6.76 M | -$7.10 M | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | -$6.41 M | -$9.22 M | -$7.54 M | -$6.76 M | -$7.10 M | — |
| EPS (Basic) | -$0.10 | -$0.14 | -$0.13 | — | -$0.14 | -$0.21 |
| EPS (Diluted) | -$0.10 | -$0.14 | -$0.13 | — | -$0.14 | -$0.21 |
| Shares Outstanding | 65.00 M | 63.96 M | 60.01 M | — | 50.67 M | 44.56 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
